Explore

Trendline Trendline
Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances

Insmed Halts Development of Skin Treatment Amid Competitive Advances
Trendline Trendline
Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges

Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges

Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges
Trendline Trendline
Gilead Sciences Acquires Tubulis to Enhance Oncology Pipeline with Advanced ADC Technology

Gilead Sciences Acquires Tubulis to Enhance Oncology Pipeline with Advanced ADC Technology

Gilead Sciences Acquires Tubulis to Enhance Oncology Pipeline with Advanced ADC Technology
Trendline Trendline
Phanes Therapeutics Expands Clinical Study of Spevatamig for Biliary Tract Cancer Treatment

Phanes Therapeutics Expands Clinical Study of Spevatamig for Biliary Tract Cancer Treatment

Phanes Therapeutics Expands Clinical Study of Spevatamig for Biliary Tract Cancer Treatment
Trendline Trendline
CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth

CenExel Appoints Dr. Sy Pretorius as CEO to Drive Strategic Growth
Trendline Trendline
Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities

Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities

Gilead Sciences to Acquire Tubulis for $5 Billion, Enhancing Cancer Treatment Capabilities
Trendline Trendline
ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury

ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury

ReAlta Life Sciences Secures $40 Million to Advance Pegtarazimod for Neonatal Brain Injury
Trendline Trendline
ConnectiveRx and EagleForce Launch ShieldRx to Combat Pharmacy Misuse

ConnectiveRx and EagleForce Launch ShieldRx to Combat Pharmacy Misuse

ConnectiveRx and EagleForce Launch ShieldRx to Combat Pharmacy Misuse
Trendline Trendline
Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies

Amylyx Pharmaceuticals to Present at Needham Virtual Healthcare Conference Highlighting New Therapies
Trendline Trendline
Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities

Gilead Sciences Acquires Tubulis for $5 Billion to Enhance Cancer Treatment Capabilities
Trendline Trendline
Compass Pathways Grants Equity Awards to New Employees Under Nasdaq Rule

Compass Pathways Grants Equity Awards to New Employees Under Nasdaq Rule

Compass Pathways Grants Equity Awards to New Employees Under Nasdaq Rule
Trendline Trendline
Pharmaceutical R Pipeline Experiences First Decline in Decades, Citeline Reports

Pharmaceutical R Pipeline Experiences First Decline in Decades, Citeline Reports

Pharmaceutical R Pipeline Experiences First Decline in Decades, Citeline Reports